A study of prevalence of metabolic syndrome in newly detected diabetes mellitus type 2

 

Sanjay T Thorat¹, Omkar R Patil², Mayur Kondewar^3*

 

¹Associate Professor, ^2,3Jr. Resident, Department of Medicine, Krishna Institute of Medical Science, Karad, Maharashtra, INDIA.

Email: mayurkon@gmail.com

REFERENCES

1. Grundy SM. Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol 1999; 83: 25F-29F.
2. Centers for Disease Control and Prevention. Diabetes Surveillance Report, 1999. Atlanta, Ga: United States Department of Health and Human Services; 1999.Available at:http:/ /www.ndep.nih.gov/campaigns/ BeSmart/ BeSmart overview.htm#. Accessed March 23, 2007.
3. Lehto S, Ronnemaa T, Haffner SM, Pyorala K, Kallio V, Laakso M. Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes 1997; 46: 1354-9.
4. Alexander CM, Landsman PB, Teutsch SM, Haffner SM. Third National Health and Nutrition Examination Survey (NHANES III); National Cholesterol Education Program (NCEP). NCEP defined metabolic syndrome, diabetes, and prevalence of Dhanaraj et al: Metabolic Syndrome in Newly Detected T2 DM 513 coronary heart disease among NHANES III participants age 50 years and older. Diabetes 2003; 52: 1210-4.
5. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB. The metabolic syndrome: prevalence and associated risk factor fi ndings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 2003; 163 : 427-36
6. Fauci. et al. Harrison's principles of internal medicine 17'th edition, vol ii. Page no 1509
7. Definition, Diagnosis and Classification of Diabetes Mellitus and its Complications, Report of a WHO Consultation, 1999.
8. Fauci. et al. Harrison's principles of internal medicine 17'th edition, vol ii. Page no 2276-77